DekaBank Deutsche Girozentrale - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$309
-41.4%
196,2000.0%0.00%0.0%
Q2 2023$527
+56.8%
196,2000.0%0.00%0.0%
Q1 2023$336
-64.7%
196,2000.0%0.00%
-66.7%
Q4 2022$951
-99.9%
196,2000.0%0.00%0.0%
Q3 2022$947,000
+30.8%
196,2000.0%0.00%
+50.0%
Q2 2022$724,000
-37.4%
196,2000.0%0.00%
-33.3%
Q1 2022$1,156,000
+344.6%
196,200
+367.1%
0.00%
+200.0%
Q4 2021$260,000
-33.2%
42,000
+2.4%
0.00%0.0%
Q3 2021$389,000
-32.6%
41,0000.0%0.00%
-50.0%
Q2 2021$577,00041,0000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders